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Cell culture
Human breast cancer cell lines MDA-MB-231 and MDA-MB-453 were cultured in Leibovitz's L-15 medium (Invitrogen, Carlsbad, CA, USA) containing 10% foetal bovine serum (FBS, HyClone, Logan, UT, USA) in 100% air without CO 2 at 37°C. The human ductal carcinoma cell line BT549 and adenocarcinoma cell line SK-BR-3 were incubated in RPMI-1640 medium (HyClone) containing 10% FBS at 37°C with 5% CO 2 . Human MCF7 breast cancer cells were cultured in Eagle's minimum essential medium (LONZA, Walkersville, MD, USA) containing 0.01 mg/ml human recombinant insulin and 10% FBS at 37°C. The human breast cell line MCF10A was cultured in DMEM/F-12 medium (HyClone) containing 100 ng/ml cholera toxin (Sigma-Aldrich, St Louis, MO, USA), 5% horse serum (Gibco BRL, Grand Island, NY, USA), 2 µg/ ml epidermal growth factor (Sigma-Aldrich), 5 µg/ml hydrocortisone (Sigma-Aldrich) and 10 µg/ml insulin (Sigma-Aldrich) at 37°C with 5% CO 2 . HEK 293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated FBS, 2 mM L-glutamine, 100 µg/mL streptomycin and 100 U/ mL penicillin in an incubator with a humidified atmosphere and 5% CO 2 at 37°C. All cell lines used were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA).
Cell transfection
The full-length cDNA of GAS5 was amplified by polymerase chain reaction (PCR) to obtain a GAS5 expression plasmid. The primers used were as follows: GAS5-XhoI-F, 5'-ccgctcgag TTTCGA GGTAGGAGTCGACTCCTGTG-3'; GAS5-BamHI-R, 5'-cgcggatcc TTTTTTTTTTTTTTTTTTTGTATTGCAAA-3'. These primers contained restriction sites for XhoI and BamHI (underlining). After double enzyme digestion, the cDNA was inserted into the pcDNA3.1-HisC vector, which was confirmed by sequencing. For GAS5 knockdown, siRNA-GAS5 was synthesized by GenePharma (Shanghai, China). miR-23a mimics and inhibitors were also purchased from GenePharma (Shanghai, China). Transient transfection of the GAS5 plasmid and siRNA or miRNA was conducted according to the instructions of Lipofectamine 2000 (Invitrogen). MDA-MB-231 or MCF7 cells were transfected with either 200 nM pcDNA3.1-GAS5/si-GAS5 or 100 nM miR-23a mimics (or miR-23a inhibitors) for 48 h. A corresponding negative control (NC) was included in all experiments.
Quantitative reverse transcription-PCR (qRT-PCR)
Total RNA of tissue and cell samples was extracted using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the instructions. Reverse-transcribed cDNA was synthesized using First Strand cDNA Synthesis Kit (Poly A Tailing) (Sangon Biotech, Shanghai, China). qRT-PCR was conducted using SYBR Premix Ex Taq II (Tli RNaseH Plus) (TaKaRa) with a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, USA). The data were analysed by the 2 -ΔΔC method. The experiment was conducted three times, and the mean value was calculated. The primer sequences are shown in Table 1 .
Electron microscopy
Breast cancer tissues and adjacent normal tissues were fixed in 2.5% glutaraldehyde and in 1% osmium tetroxide buffer, embedded in spur resin and cut into thin sections. The thin sections were stained with a saturated solution of uranylacetate and lead citrate and examined using a JEOL 1200EX transmission electron microscope at 220 kV.
Detection of autophagosome formation
Localization of exogenous LC3B fused to enhanced green fluorescent protein (EGFP-LC3B) was employed to detect autophagosome formation in breast cancer cells. Transfection of the EGFP-LC3B expression plasmid (Addgene, plasmid# 11546; Cambridge, MA, USA) was performed with Lipofectamine Cellular Physiology and Biochemistry
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LTX and PLUSTM reagent (Invitrogen) according to the instructions, and GFP localization was immediately observed by fluorescence microscopy. Cells with multiple punctate EGFP-LC3B-labelled vacuoles were identified for quantification, and the number of green fluorescent puncta present was calculated using ImageJ software (National Institutes of Health, USA).
Monodansylcadaverine (MDC) staining for autophagic vacuoles
MDC is a specific in vivo marker for autophagic vacuoles. MDAMB-231 and MCF7 cells grown on coverslips were treated with 5 μM 4-hydroxytamoxifen (4-OHT) for 48 h. The cells were then stained with 50 μM MDC (Sigma-Aldrich Chemical Company, St Louis MO, USA) at 37°C for 15 min in the dark. After washing with phosphate-buffered saline (PBS), the cells were visualized under a fluorescence microscope (Leica, Wetzlar, Germany).
RNA immunoprecipitation (RIP) assay
The MS2bs-MS2bp-based RNA RIP assay was performed based on a previous report [26] . The plasmids pSLMS2-12X (#27119, Addgene plasmid) and pMS2-GFP (#27121, Addgene plasmid) were obtained from Robert Singer. As described by a previous study [27] , the sequences of GAS5 and MS2-12X were inserted into the pcDNA3.1 plasmid, and the miR-23a complementary site of the sequence of AAUGUG in GAS5 was mutated by deletions to remove miR-23a complementarity. Cells were then co-transfected with pcDNA3.1-GAS5-MS2, pcDNA3.1-GAS5-mut-MS2, or pcDNA3.1-MS2 + pMS2-GFP. After transfection for 48 h, the RIP assay was performed with a anti-GFP antibody (Roach) and Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore, Bedford, MA, USA). Normal mouse IgG and snRNP70 were used as negative (NC) and positive controls, respectively. miR-23a expression was analysed by qRT-PCR. Total RNA (input controls) and IgG was assessed at the same time to demonstrate that the detected signals were the result of miR-23a specifically binding to GAS5.
Dual luciferase reporter gene assay HEK 293T cells (2 × 10

4
) were cultured in a 24-well plate. The GAS5 sequence containing the predicted miR-23a binding site was subcloned and inserted into the pmirGLO vector (Promega, Madison, WI, USA). The 3'-untranslated region (UTR) of ATG3 containing the predicted miR-23a binding site was obtained from GENEWIZ (Suzhou, China), subcloned and inserted into the pmirGLO vector. HEK 293T cells (2 × 10 4 ) were incubated in a 96-well plate and co-transfected with recombinant plasmids or the empty pmirGLO vector (200 ng) and miR-23a mimics or NC (50 nM). After transfection for 24 h, luciferase activity was measured with the dual luciferase reporter assay system (Promega). Firefly luciferase activity was normalized against that of Renilla luciferase.
Western blotting
Total protein was separated by 10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride membranes (0.45 µm) (Millipore, Billerica, MA, USA), which were blocked with 5% non-fat milk. The membranes were incubated with primary antibodies, namely, anti-LC3B (1:1000, Novus Biologicals), anti-p62 (1:1000, Santa Cruz), anti-ATG3 (1:1000, Cell Signaling Technology) and anti-β-actin (1:1000, Sigma-Aldrich), at 4°C overnight. Subsequently, the membranes were incubated with anti-rabbit/mouse IgG secondary antibodies (1:10000, Jackson). The protein bands were visualized by the addition of enhanced chemiluminescent substrate (ECL, Pierce, USA).
Immunohistochemical staining
Fresh cancer tissue samples without necrotic tissues were sectioned into 0.4-cm sections, fixed in 10% formaldehyde solution for 24 h, embedded by conventional paraffin and then cut into 3-nm paraffin sections. Immunohistochemical staining was conducted according to the manufacturer's instructions. The paraffin sections were immunostained with anti-LC3B (Cell Signaling Technology), anti-p62 (Santa Cruz Biotechnology) and anti-ATG3 (Santa Cruz Biotechnology) antibodies and horseradish peroxidase-labelled goat anti mouse IgG (1:150). The sections were developed by the addition of 3, 3′-diaminobenzidine (DAB) and stained with haematoxylin. Cytoplasm appearing as brown particles indicated positive results. Under a microscope, 5 high-power fields were selected to calculate the number of positive cells (Olympus).
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Subcutaneous xenograft nude mouse model A total of 15 female nude mice, aged 4 to 6 weeks and purchased from the Shanghai Experimental Animal Center of the Chinese Academy of Sciences, were assigned into three groups of 5 mice each. Each nude mouse was injected in the oxter with the MCF7 cell line. MCF7 cells were transfected with LV/mimics NC, LV-GAS5/mimics NC, or LV-GAS5/miR-23a mimics and injected into the mice. LV is a lentiviral empty vector, and LV-GAS5 is a lentiviral vector with GAS5 knockout; both were purchased from GenePharma (Shanghai, China). Intratumoural injection was performed twice per week, and the tumour volume was measured once a week (the observation lasted 4 weeks after the first injection). After 4 weeks, each nude mouse was euthanized, and the subcutaneous tumours were excised to conduct immunohistochemical staining.
Statistical analysis
Statistical analysis was conducted in SPSS 19.0 (SPSS, Inc, Chicago, IL, USA). Measurement data are presented as the mean ± standard deviation. Student's t-test and one-way analysis of variance (ANOVA) (a homogeneity test of variance was performed before the analysis) were used to determine the significance of differences between two groups or among multiple groups, respectively. P < 0.05 was considered significantly different.
Results
Expression of GAS5 in breast cancer tissues and breast cancer cell lines
qRT-PCR was used to detect GAS5 expression in 68 breast cancer and 68 adjacent normal tissues. GAS5 expression was down-regulated in breast cancer tissues compared with adjacent normal tissues (P < 0.05) (Fig. 1A) . Correlation between GAS5 expression and clinicopathological features was then assessed, and the results indicated that GAS5 expression was significantly correlated with TNM stage and tumour size. ER(-) breast cancer tissues presented decreased GAS5 expression compared with that of ER(+) breast cancer tissues (P < 0.01, Fig. 1B -D, Table 2 ). Overall, these results demonstrate that GAS5 may be a potential prognostic biomarker for patients with breast cancer. In addition, GAS5 expression in five human breast cancer cell lines, namely, MDA-MB-23l, MDAMB-453, BT549, SK-BR-3 and MCF-7 cells, and in the normal breast epithelium cell line MCF-10A was detected; the results revealed that compared with MCF-10A cells, breast cancer cells had significantly lower expression of GAS5 (P < 0.01, Fig. 1E ). Among the five breast cancer cell lines, the highest expression of GAS5 was found in MCF-7 cells, whereas MDA-MB-23l cells showed the lowest expression. Thus, the MCF-7 cell line was selected for a GAS5 interference experiment and the MDA-MB-23l cell line for a GAS5 overexpression experiment.
GAS5 is mainly localized in the cytoplasm
The subcellular localization of lncRNAs and MDA-MB-231 cells were cultured for isolation of nuclear and cytoplasmic fractions, and proteins in the fractions were assessed by western blotting, which demonstrated successful isolation. qRT-PCR showed GAS5 to be at significantly higher levels in the cytoplasm of MCF10A and MDA-MB-231 cells than in nuclei, suggesting that GAS5 is mainly localized in the cytoplasm ( Fig. 2A-C) .
GAS5 promotes autophagy in breast cancer cells
To examine the regulatory effect of lncRNA GAS5 on autophagy, pcDNA3.1-GAS5 was transfected into the breast cancer cell line MDA-MB-23l, with nearly 15-fold expression compared to cells carrying the empty plasmid. si-GAS5 was transfected into MCF-7 cells, and its silencing efficiency was approximately 70% (Fig. 3A) . After overexpression of GAS5, qRT-PCR and western blotting detection of expression of autophagy markers LC3, ATG3 and p62 showed significantly increased conversion rates of LC3 I to II as well as ATG3 expression, whereas p62 expression was significantly decreased; however, the opposite trend was found after si-GAS5 transfection ( Fig. 3B  and C) . The results suggest that GAS5 promotes autophagy in breast cancer cells. A large number of autophagic vacuoles were observed by transmission electron microscopy after overexpression of GAS5, but decreased autophagic vacuoles were found with si-GAS5 (Fig.  3D) . Moreover, sites of EGFP fluorescence were observed by confocal microscopy after transient transfection of the EGFP-LC3 plasmid in MDA-MB-231 and MCF-7 cells for 48 h, whereby bright green fluorescent dots represent autophagosome formation. The number of bright green fluorescent dots increased significantly after overexpression of GAS5; in contrast, green fluorescent dots decreased significantly after GAS5 interference (Fig. 3E) . These findings further confirmed that GAS5 promotes autophagy in breast cancer cells. -∆Ct method was used for data analysis, * represents factor analysis of variance was used; *P<0.05, nuclear fractions were compared with cytoplasmic fractions; **P<0.01, suggesting a statistically significant difference, n = 3. (Fig. 4A) . As miR-23a has been proven to be involved in the regulation of autophagy [28] , GAS5 wt/mut was cloned into the double luciferase reporter gene vector (pmirGLO) and co-transfected into HEK-293T cells with miR-23a mimics and mimics NC to verify the targeting effect of miR-23a on GAS5. Fig. 4B shows that overexpression of miR-23a significantly reduced the luciferase activity of the wildtype (WT) reporter (P < 0.05) but not that of the empty vector (P > 0.05) or the mutant reporter (P > 0.05), suggesting that GAS5 can be targeted by miR-23a through this binding site. To validate direct binding between miR-23a and GAS5 at the endogenous level, we performed an RNA immunoprecipitation (RIP) assay with MS2-binding protein (MS2bp), which specifically binds RNA containing MS2-binding sequences (MS2bs) to pull down endogenous miRNAs associated with GAS5. Based on the results of qRT-PCR analysis, GAS5 RIP was significantly enriched for miR23a in MCF-7 cells compared with the empty vector (MS2), IgG (used as a negative control) and GAS5 with mutated miR23a targeting sites (GAS5-mut (miR-23a)) ( Fig. 4C and D) . Transmission electron microscopy was used to detect autophagy in MDA-MB-23l and MCF-7 cells after overexpression or down-regulation of GAS5; the white arrow indicates the bilayer structure of typical autophagic vacuoles, and the black arrow refers to the primary autophagic body (× 1700). (E) MDA-MB-23l and MCF7 cells were co-transfected with GFP-LC3 and pcDNA3.1, pcDNA3.1-GAS5, si-NC or si-GAS5 for 48 h. Cells were imaged by confocal microscopy (scale bar = 10 μm). All data are presented as the mean ± SD; three replicates were performed. *P<0.05 vs. the empty plasmid or negative control.
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GAS5 is predicted to be a ceRNA of ATG3 via direct binding of miR-23a
lncRNAs acts as a ceRNA to exert its regulatory functions. The online prediction software MicroInspector (http:// b i o i n f o . u n i -p l o v d i v. b g / microinspector/) was used to predict lncRNA-targeted miRNAs, and the results indicated that GAS5 contains a binding site for miR-23a
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To verify the observed interaction between GAS5 and miR-23a, miR-23a mimics/ mimics NC and miR-23a inhibitor/inhibitor NC (50 nmol/L) were transfected into MDA-MB-23l and MCF-7 cells, respectively. After 24 h of transfection, relative expression of GAS5 was detected by qRT-PCR, with a negative correlation found between GAS5 and miR23a (Fig. 4E) . si-GAS5 and si-NC were transfected into MCF-7 cells at the same concentrations.
qRT-PCR showed that after downregulation or up-regulation of GAS5, no significant changes in Pri-miR-23a and Pre-miR-23a were observed, and only the relative expression of mature miR-23a was significantly increased or decreased, respectively (Fig. 4F) . Thus, the results suggest that GAS5 may negatively regulate expression of miR-23a at the post-transcriptional level.
A d d i t i o n a l l y , bioinformatic analysis with the use of DIANA Tools suggested the presence of a common binding site for miR-23a between GAS5 and ATG3 (Fig.  4A) . Accordingly, a reporter gene vector, pmirGLO-ATG3 3'UTR, was constructed based on the binding sites of miR23a and ATG3 predicted by the database. ATG3 3'UTR wt/ mut was cloned into pmirGLO and then co-transfected with miR-23a mimics or mimics NC into HEK-293T cells to conduct a dual luciferase reporter gene assay. As shown in Fig.  4G , overexpression of miR-23a significantly reduced the luciferase activity of the pmirGLO-ATG3 3'UTR vector (P = 0.001) but did not attenuate that of the blank control vector (P > 0.05), suggesting that ATG3 can be directly targeted by miR-23a. Furthermore, qRT-PCR and western blotting assays revealed that ATG3 expression was significantly decreased after overexpression of miR-23a and was significantly increased after down-regulation of miR23a ( Fig. 4H , P < 0.001), indicating that miR-23a can negatively regulate expression of ATG3 at the RNA and protein levels. ; (E) After miR-23a mimics/mimics NC or miR-23a inhibitors/inhibitors NC was transfected into MDA-MB-23l and MCF-7 cells, respectively, GAS5 expression was detected by qRT-PCR; the results showed that miR-23a inhibits expression of GAS5 (GAPDH as internal reference). (F) After pcDNA3.1/pcDNA3.1-GAS5 or si-GAS5 and si-NC were transfected into MDA-MB-23l and MCF-7 cells, respectively, miR-23a expression was detected by qRT-PCR. The results showed that GAS5 inhibits expression of miR-23a (U6 as internal reference). (G) A dual luciferase reporter gene assay was performed in HEK293T cells. (H, I) qRT-PCR and western blotting showed that miR-23a significantly reduces ATG3 expression. All data are presented as the mean ± SD; three replicates were performed. *P<0.05, **P<0.01, ***P<0.01.
miR-23a mimics significantly inhibit autophagy in breast cancer cells
As shown in Fig. 5A , we found that miR-23a mimics significantly inhibited autophagy in breast cancer cells but that miR-23a inhibitors promoted autophagy in these cells. Western blotting results also showed decreases in the ratio of LC3BII/I and ATG3 expression but increases in p62 expression in the miR-23a mimic group; the miR-23a inhibitor group showed the opposite trend. The application of chloroquine diphosphate (CQ) blocked autophagy flow induced by miR-23a inhibitors, and expression of LC3BII/I and p62 showed an obvious cumulative effect. Bright punctate fluorescence with MDC-positive staining in cells was observed by inverted fluorescence microscopy, enabling a rough evaluation of the number of autophagic vacuoles under the influence of different treatment factors and thus an understanding of the level of autophagy. Compared with the NC group, fluorescence was decreased in each cell of the miR-23a mimic group, whereas miR-23a showed the opposite trend. In addition, CQ significantly blocked autophagic vacuole formation induced by miR23a inhibitors (Fig. 5B) .
The regulation of lncRNA GAS5-miR-23a axis of ATG3
We overexpressed or silenced expression of GAS5 in MDA-MB-23l and MCF-7 cell lines and used qRT-PCR to detect ATG3mRNA expression. The results showed that expression of GAS5 was positively correlated with ATG3 (Fig. 6) ; results presented above also revealed that ATG3 expression was negatively correlated with miR-23a ( Fig. 4H and I) .
The effect of GAS5 on autophagy is rescued by miR-23a
To further verify that lncRNA GAS5 mediates autophagy through interaction with miR23a, we performed compensation experiments at the mRNA and protein levels. MDA-MB-23l and MCF-7 cell lines were assigned into groups of pcDNA3.1 + miR-23a inhibitors (pcDNA3.1 + inhibitors), pcDNA3.1-GAS5 + miR-23a inhibitors (pcDNA3.1-GAS5 + inhibitors), si-NC + miR-23a mimics (si-NC + mimics) and si-GAS5 + miR-23a mimics (si-GAS5 + mimics). The results confirmed the above experimental results. As presented in Fig. 7A and B, qRT-PCR and western blotting revealed that compared with the pcDNA3.1-NC + inhibitor group, the pcDNA3.1-GAS5 + inhibitor group exhibited a decreased LC3BII/I ratio and ATG3 expression but increased expression of p62. Compared with the si-NC + mimic group, the si-GAS5 + mimic group had an increased LC3BII/I ratio and ATG3 expression but decreased expression of p62. These results demonstrate that GAS5-mediated autophagy is achieved through interaction with miR-23a. 
The effect of the GAS5-miR-23a axis on autophagy in nude mice
We found that the ratio of LC3BII/I and ATG3 expression was decreased but that expression of p62 was increased in tumour tissues of mice transfected with LV + mimics NC, LV-GAS5 mimics NC and LV-GAS5 miR-23a mimics, suggesting that autophagy flow was gradually suppressed in the three groups (Fig. 8A) . The results of immunohistochemical staining were similar to those of western blotting, with the staining score of ATG3 decreasing successively and that of p62 increasing successively (Fig. 8B) . These results partially demonstrate the regulation of autophagy by the GAS5-miR-23a axis in nude mice.
Discussion
Breast cancer is a molecularly heterogeneous disease and the most common cancer affecting women all worldwide [29] . A previous study demonstrated that autophagy regulation has different and even opposite effects in breast cancer, indicating the need for a selection strategy when aiming to modulate autophagy in cancer therapy [30] . Interestingly, lncRNAs are reported to be critical regulators involved in tumour-related apoptosis, autophagy, and metastasis [31] . Thus, we investigated the ceRNAdependent role of the lncRNA GAS5 in the development of breast cancer. We conclude that GAS5 acts as a miRNA sponge in a pathway that includes miR-23a and its target gene ATG3 and that the GAS5-miR-23a-ATG3 axis significantly regulates autophagy in breast cancer.
We assessed lncRNA GAS5 expression in breast cancer tissues and cell lines, and the results showed down-regulation in breast cancer tissues compared with adjacent normal tissues. Down-regulated expression of GAS5 has been found in multiple cancers, including breast cancer [32, 33] . In line with the results of our study, Mourtada-Maarabouni et al. reported decreased GAS5 expression in breast cancer cells, indicating such a decrease in expression may be important in oncogenesis [34] . Furthermore, our study also found low expression of GAS5 to be closely related to a larger tumour size, advanced TNM stage and Compensation experiments for miR-23a and GAS5 at the protein level.Notes: MDA-MB-23l and MCF-7 cell lines were assigned into groups of si-NC + miR-23a inhibitors (si-NC + inhibitors), si-GAS5 + miR-23a inhibitors (si-GAS5 + inhibitors), si-NC + miR-23a mimics (si-NC + mimics) and si-GAS5 + miR23a mimics (si-GAS5 + mimics). qRT-PCR and western blotting were used to detect mRNA and protein expression of autophagyrelated genes LC3, ATG3 and p62. All data are presented as the mean ± SD of three replicates. *P<0.05. ER(-) breast cancer. Low levels of GAS5 have been correlated with advanced TNM stage, histological grading, and poor disease-free survival, overall survival and prognosis [35] , consistent with our results. Additionally, low expression of GAS5 was found to be significantly associated with tumour size in hepatocellular carcinoma [19] .
Our study demonstrated that GAS5 promotes autophagy in breast cancer cells: the conversion rate of LC3 I to II and ATG3 expression were significantly increased after overexpression of GAS5, whereas expression of p62 was significantly decreased; the opposite trend was found after si-GAS5. A previous study noted that autophagy can function as a unique caspaseindependent mechanism of cell death, which is known to be distinct from apoptosis and necrosis [36, 37] . Recently, many types of proteins involved in the execution of autophagy have been categorized as autophagyrelated proteins (ATGs), and approximately 30 autophagy-related genes have been identified as participating in different stages of autophagy [38] [39] [40] [41] . In addition to autophagic vacuoles, there are many other specific features of autophagic cell death, including Beclin-1 (ATG6), ATG5, ATG3, ATG12, or ATG7 involvement and LC3-I to LC3-II conversion [42] . p62 is also considered a selective autophagy substrate, and accumulating evidence indicates that p62 can function as a cargo receptor for selective autophagy of various ubiquitinated substrates [43] . Importantly, overexpression of GAS5 was found to inhibit autophagic responses in osteoarthritis [44] , which was, to a certain extent, confirmed by our results with regard to breast cancer.
It has been reported that lncRNAs affect post-transcriptional regulation by interfering with miRNA pathways, acting as ceRNAs [45] . Our study also revealed that GAS5 can be used as a "molecular sponge" to block and bind miR-23a, thereby positively modulating the miR23a targeted autophagy-related gene ATG3. Here, we first put forward the involvement of the lncRNA-GAS5/miR-23a/ATG3 axis in breast cancer, as confirmed by luciferase reporter gene, RIP, qRT-PCR and western blotting assays. The luciferase reporter gene assay revealed that miR-23a can bind to the seed sequence of GAS5, and RIP experiments demonstrated that interaction of the two in the RNA-induced silencing complex (RISC) was facilitated by the Ago2 protein, thus resulting in mutual inhibition. In addition, qRT-PCR and western blotting confirmed the interrelationship between miR-23a and GAS5 at the transcriptional and protein levels. A previous study has shown that the lncRNA GAS5 can negatively regulate expression of miR-23a and that it can act as a miR-23a sponge [46] , which was in line with our conclusion. Furthermore, there is evidence that GAS5 expression is decreased in gastric cancer tissues and is negatively related to increased miR-23a expression [35] . Interestingly, miR-23a functions as an autophagy inhibitor in breast cancer cell lines, and overexpressed miR-23a was found to inhibit the invasive and migration abilities of melanoma cells by abolishing autophagy by directly targeting ATG12 [28] . In addition, a previous study also found that ATG3 was targeted by miR-23a, with qRT-PCR and western blotting confirming the regulatory effect of miR-30b on ATG3, suggesting that ATG3 is an autophagy-related ceRNA that functions with GAS3 in a manner similar to that of an MRE. Through a series of 
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validation experiments, we demonstrate that GAS5 inhibits the abundance of miR-23a by interacting with it, thus indirectly alleviating the inhibitory effect of miR-23a on the target gene ATG3 and culminating in a positive regulatory effect. Taken together, our study provides evidence that by regulating autophagy pathways, the GAS5-miR-23a-ATG3 axis may be regarded as a key regulator in breast cancer, as also confirmed in a subcutaneous xenograft nude mouse model. This study reveals that the GAS5-miR-23a-ATG3 axis might be used as a promising biomarker and therapeutic target in the future, though the relevant mechanisms need to be further studied.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
